Skip to content

The Sensitivity and Specificity of CardioSimFFRct Analysis Software on Coronary Artery Stenosis

A Clinical Trial on the Diagnostic Performance Based on CT-Derived Fractional Flow Reserve Score Analysis Software for Coronary Artery Stenosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04569669
Enrollment
325
Registered
2020-09-30
Start date
2020-10-09
Completion date
2022-03-09
Last updated
2020-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Stenosis

Brief summary

The device involved in this trail is a diagnostic software with a Prospective, Multicenter, Self Controlled design. FFRCT diagnostic performance was calculated by CardioSimFFRct Analysis software, and the diagnostic accuracy, sensitivity, specificity, positive predictive value and negative predictive performance of FFRCT for myocardial ischemia were calculated per-patient level and per-vessel level with invasive FFR value as gold standard.

Detailed description

The present study is a single arm, open label, prospective trial. Measurement of FFR during invasive cardiac catheterization represents the gold standard for assessment of the hemodynamic significance of coronary artery lesions. As we know, the major disadvantage of FFR is that it has to be measured invasively. CardioSimFFRct Analysis software is a non-invasive method to determine FFR which computes the hemodynamic significance of Coronary Artery Disease (FFRCT) from coronary computed tomography angiography(CCTA)data of the subject by using computational fluid dynamics.The FFR derived from FFR-CT will be compared with invasive FFR as gold standard.Moreover CardioSimFFRct also simplifies the coronary artery into a one-dimensional piping model, omits grid engineering, and greatly reduces the complexity of pretreatment.Based on the pressure loss along the pipe flow and the local pressure loss, a fast method for FFR calculation in engineering is proposed. The calculation time can be reduced to several minutes. FFRct from CardioSimFFRct Analysis software is mainly based on CCTA images to image the coronary arteries. Through three-dimensional reconstruction of the coronary arteries and computational fluid Dynamics (CFD) technology, the simulation of blood flow in the blood vessels is realized to extract the coronary blood flow reserve score (FFR).FFRct has the following characteristics such as the FFR value can be measured noninvasively, without additional damage to patients, avoiding the risks brought by invasive surgery, and the side effects brought by drugs during invasive surgery.FFRct can realize the examination quickly, save the time of doctors' coronary functional assessment, and simplify the process of coronary functional assessment.It also has the function of three-dimensional reconstruction of blood vessels, which makes it convenient for users to view the whole structure of coronary arteries and make artificial correction.The results of FFRct have high repeatability and are easy for users to evaluate.

Interventions

DIAGNOSTIC_TESTFFR and FFRCT

All the patients will undergo computed coronary tomography angiography to analysis FFRCT . Then FFR will be measured during invasive cardiac catheterization.

Sponsors

Shengshi Technology, Co., Ltd, Hangzhou, China
CollaboratorUNKNOWN
CCRF Inc., Beijing, China
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Subjects that participate in this study must fulfill all the following criteria: General inclusion criteria: * Age ≥18 years and ≤ 80 years; * Subject providing written informed consent; * After the researcher assessed the suspected presence of coronary artery stenosis, coronary angiography and CCTA examination were proposed. Angiographic inclusion criteria: * CCTA inspection should be performed on instruments with at least 64 multidetector rows; * CCTA images are clear and readable; * The diameter of coronary artery lesion stenosis was measured by CCTA image with 30%-90%; * The reference vessel diameter of coronary stenosis was ≥2.5mm by CCTA imaging.

Exclusion criteria

If subjects fulfill any of below criteria, this subject shall be exclude from this study. General

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificity (subject level) of FFRCTMeasurement at Procedure/Baseline VisitSensitivity and specificity (subject level) for predicting the functional significance of coronary artery stenosis using CT-Derived Fractional Flow Reserve Score Analysis Software.

Secondary

MeasureTime frameDescription
AUC between FFRCT vs. FFRMeasurement at Procedure/Baseline VisitComparing the Area Under Curve(AUC) between FFRct and CCTA to determine the Functional significance of coronary stenosis.
Sensitivity and Specificity between FFRCT vs. FFRMeasurement at Procedure/Baseline VisitComparing the Sensitivity and Specificity which at the lesion level between FFRct and CCTA
Accuracy (lesion level and subject level) between FFRCT vs. FFRMeasurement at Procedure/Baseline VisitComparing the Accuracy which at the lesion level and subject level between FFRct and CCTA
Positive Predictive Value (PPV) between FFRCT vs. FFRMeasurement at Procedure/Baseline VisitComparing the positive predictive value (PPV) between FFRct and CCTA
Negative Predictive Value (NPV) between FFRCT vs. FFRMeasurement at Procedure/Baseline VisitComparing the negative predictive value (NPV) between FFRct and CCTA

Countries

China

Contacts

Primary ContactYaling Han, professor
hanyaling@263.net+86-024-28851120

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026